STOCKS NEWS US-Acadia, Biovail plan more study on drug

Stocks on the move [HOT-RTRS]

Real-time Equity news [U E] [RESF/US]

U.S. stock market report [.N]
0822 ET 06Oct2009-Acadia, Biovail plan more study on drug
------------------------------------------------------------------------------

Acadia Pharmaceuticals Inc (ACAD.O) and its partner Biovail
Corp BVF.N BVF.TO on Tuesday said they decided to conduct a
third late-stage trial for their experimental drug for
psychosis related to Parkinson's disease that failed in a
late-stage trial last month.

The companies agreed to use the findings from the failed
study along with the data from a second, ongoing late-stage
study, to arrive at an enhanced study design that may be used
in the third late-stage trial.

For details, see [ID:nBNG167642]

Shares of Acadia gained 20 percent to $1.98 in premarket
trading while U.S.-listed shares of Biovail closed Monday at
$14.70.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0815 ET 06Oct2009-Australian rate hike lifts futures
------------------------------------------------------------------------------

U.S. stock index futures rose on Tuesday on renewed hopes
for a global economic recovery after Australia raised interest
rates and in anticipation of the start of an improved earnings
season.

For details, see [ID:nN06414746]

Dow Jones industrial average futures DJc1 rose 72 points,
while S&P 500 futures SPc1 gained 8.3 points, and Nasdaq 100
futures NDc1 were up 11.5 points.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0807 ET 06Oct2009-Constellation Energy shuts reactor
------------------------------------------------------------------------------

Constellation Energy Group Inc (CEG.N) shut the
621-megawatt Unit 1 at the Nine Mile Point nuclear power
station in New York from full power on Oct. 5, the company told
the U.S. Nuclear Regulatory Commission in a report.

The company shut the reactor due to a failure of the
feedwater level control system.

For details, see [ID:nN06414577]

Shares of Constellation closed Monday at $31.69.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0756 ET 06Oct2009-Emerson to buy Avocent for $1.2 bln
------------------------------------------------------------------------------

Emerson Electric Co (EMR.N) agreed on Tuesday to buy
Avocent Corp AVCT.O for about $1.2 billion.

Under the agreement, Emerson will pay $25 for each share of
Avocent, a premium of 22 percent to the company's Monday
closing price.

For details, see [ID:nBNG531147]

Shares of Emerson edged 0.1 percent higher to $38.70 in
premarket trading on light volume, while Avocent climbed 21
percent to $24.80 before the bell.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0746 ET 06Oct2009-Sequenom says cooperating with probes
------------------------------------------------------------------------------

Sequenom Inc (SQNM.O) said late Monday it was cooperating
with multiple probes, both legal and regulatory.

The disclosures came after a scandal over the mishandling
of key clinical data involving its prenatal Down Syndrome test
led to most of the company's top management team resigning last
week.

The company met with representatives from the U.S. Attorney
for the Southern District of California and the FBI in
connection with their respective investigations.

For details, see [ID:nBNG489092]

Shares of Sequenom closed Monday at $3.02.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net